Ambassador views Teva CEO as important player in potential vaccine alliance
Incoming Teva CEO Jeremy Levin attends a news conference in Tel Aviv January 2, 2012. Teva Pharmaceutical Industries, the world's largest generics drugmaker, said on Monday that Shlomo Yanai would step down
Kåre Schultz new CEO of Teva - Nordic Life Science – the leading Nordic life science news service
Teva CEO Erez Vigodman Steps Down | CHEManager
New Teva CEO shakes up structure and executive ranks as major layoffs loom | Fierce Pharma
Erez Vigodman steps down as Teva CEO
Teva CEO Vigodman Steps Down After Poor Outlook for 2017 | Fortune
Teva CEO exits in ongoing crisis of confidence at drugmaker | Reuters
Teva chooses new CEO
Teva CEO Vigodman steps down as drugmaker seeks direction | The Times of Israel
Teva CEO Sees a Final Opioid Settlement Coming This Year | Barron's
Teva CEO Erez Vigodman to Step Down - WSJ
New Teva CEO reorganizes with an 'ax, not hedge clippers or pruning shears' - STAT
Teva CEO: We have to launch new products - Globes
Teva CEO Schultz took a big pay cut last year—but he bagged a contract extension, too | Fierce Pharma
Teva CEO: Company Would Have Gone Bankrupt Without Layoffs - Haaretz.com
Where is Kåre Schultz? | Ctech
US Congress grills Teva CEO on Copaxone price hikes - Globes
After turbulent years, Teva CEO Schultz forecasts stability - Israel News - The Jerusalem Post
Teva Pharmaceutical CEO on Bringing His Company Back from the Brink | Barron's
Teva Appoints Lundbeck's Schultz as CEO | Ctech
Teva CEO on decimated share price: "It's rational enough from a market point of view"
Teva's new CEO shakes up management, to combine divisions | Reuters
